Netazepide
- Generic Name
- Netazepide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H30N6O3
- CAS Number
- 155488-25-8
- Unique Ingredient Identifier
- HOU4I0G29C
- Background
Netazepide has been used in trials studying the prevention and treatment of Dyspepsia, Hypergastrinaemia, Barrett's Esophagus, ECL-cell Hyperplasia, and Rebound Hyperacidity, among others.
- Associated Conditions
- -
- Associated Therapies
- -
Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-12-03
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- Trio Medicines Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02620696
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath